The bioinformatics services market size has grown rapidly in recent years. It will grow from $4.15 billion in 2024 to $4.78 billion in 2025 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to genomic research advancements, rise in personalized medicine, pharmaceutical R&D investments, biological data explosion, government initiatives in healthcare, increasing adoption of next-generation sequencing (NGSs)
The bioinformatics services market size is expected to see rapid growth in the next few years. It will grow to $9.38 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to expanding role in clinical diagnostics, growing importance in agriculture and environmental sciences, increasing collaboration in research, rising demand in drug repurposing. Major trends in the forecast period include digital health initiatives, technological advancements in sequencing, ai and machine learning integration, cloud-based solutions, personalized medicine and genomic analysis, integration of blockchain for data security.
The growing adoption of information technology in the healthcare sector is anticipated to significantly enhance the bioinformatics services market in the future. This rise in technology usage has enabled healthcare professionals to elevate the quality of care they deliver to patients, enhance patient safety, improve operational efficiency, reduce costs, and foster better communication among healthcare providers. Bioinformatics services, which leverage computer science and statistics to analyze biological data, rely heavily on IT infrastructure. For example, a report from the National Center for Health Statistics, a U.S. government agency, indicated that in December 2022, 58.5% of adults in the U.S. turned to the Internet for health or medical information, 41.5% used it to connect with doctors or their offices, and 46.1% sought medical test results online. Consequently, the rising integration of information technology in healthcare is propelling the expansion of the bioinformatics services market in the coming years.
The rising demand for personalized medicine is anticipated to significantly drive the expansion of the bioinformatics services market in the future. Personalized medicine is an innovative healthcare approach that considers individual differences in patients' genetics, environments, and lifestyles. Bioinformatics plays a crucial role in personalized medicine by identifying genetic variations, predicting disease risk, analyzing genomic and proteomic data, and safeguarding sensitive health information. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is fueling the growth of the bioinformatics services market moving forward.
Technological advancements serve as a prominent trend shaping the bioinformatics services market, with companies leveraging innovative technologies to fortify their positions. An illustrative example is bitBiome Inc.'s July 2022 launch of the Enzyme Discovery service, leveraging the world's largest microbial genome database (MMGDB) and distinctive bioinformatics technologies. Employing their fundamental technology, bit-MAP, for microbial single-cell genome analysis, bitBiome's service analyzes the human microbiome and environmental bacteria, offering enzyme discovery services through unique bioinformatics and 3D structural modeling technologies.
Leading companies in the bioinformatics services sector prioritize introducing innovative bioinformatic tools offering advanced data solutions, particularly in epigenetic data analysis. FOXO Technologies Inc.'s July 2023 launch of 'Bioinformatics Services' exemplifies this focus, delivering a comprehensive platform equipped with cutting-edge tools for accelerated epigenetic data analysis. These tools significantly boost speed and accuracy in data results, contributing to the processing, analysis, and interpretation of complex disease-related data, thereby expediting research and enhancing comprehension in the field.
In May 2022, ZS, a US-based management consulting company, completed the acquisition of Intomics A/S for an undisclosed amount. This strategic move aims to expand and diversify ZS's portfolio by integrating deep data, scientific expertise, academia, technology, and artificial intelligence. The synergy resulting from this acquisition is expected to expedite drug discovery processes and enhance the probability of success for new pharmaceuticals. Intomics A/S, based in Europe, specializes in bioinformatics and systems biology, operating within the bioinformatics services market.
Major companies operating in the bioinformatics services market include QIAGEN Digital Insights, Thermo Fisher Scientific Inc., Illumina Inc., DNAnexus Inc., PerkinElmer Inc., Biomax Informatics AG, Life Technologies Corporation, BGI Group, Eurofins Scientific SE, NeoGenomics Laboratories Inc., CD Genomics Inc., MedGenome Labs Pvt. Ltd., Fios Genomics Ltd., Geneva Bioinformatics SA, GVK Biosciences Private Limited, Accelrys Inc., Macrogen Inc., GENEWIZ Inc., Source BioScience Limited, Microsynth AG, BaseClear B.V., DNASTAR Inc., GATC Biotech AG, Partek Incorporated, Seven Bridges Genomics Inc., Omixon Inc., BioTeam Inc., BioBam Bioinformatics S.L., Biomatters Limited, Genomatix GmbH, DNASTREAM Limited, Genalice B.V., Golden Helix Inc., Strand Life Sciences Private Limited.
North America was the largest region in the bioinformatics services market in 2024. Europe is expected to be the fastest-growing region in the global bioinformatics services market report during the forecast period. The regions covered in the bioinformatics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioinformatics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Bioinformatics services encompass a broad spectrum of computational tools, resources, and analyses applied in the realm of bioinformatics. These services involve scrutinizing connections between technical and biological variables within studies, encompassing tasks such as sample metadata assessment, data quality control, and standardization across samples.
The primary categories of bioinformatics services include sequencing services, data analysis, drug discovery services, differential gene expression analysis, database management, and various other specialized bioinformatics services. Sequencing services involve deciphering the exact sequence of nucleotides within a given sample. Specialized domains within bioinformatics services span medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The applications of these services are diverse, encompassing genomics, chemoinformatics, drug design, proteomics, transcriptomics, metabolomics, and other fields. End-users of bioinformatics services include academic institutes, research centers, hospitals, clinics, pharmaceutical and biotechnology companies, contract research organizations (CROs), and various other end-user entities.
The bioinformatics services market research report is one of a series of new reports that provides bioinformatics services market statistics, including bioinformatics services industry global market size, regional shares, competitors with a bioinformatics services market share, detailed bioinformatics services market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics services industry. This bioinformatics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics services market includes revenues earned by entities through single-cell analysis, proteomics analysis, metabolomics analysis, and epigenetics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
The bioinformatics services market size is expected to see rapid growth in the next few years. It will grow to $9.38 billion in 2029 at a compound annual growth rate (CAGR) of 18.4%. The growth in the forecast period can be attributed to expanding role in clinical diagnostics, growing importance in agriculture and environmental sciences, increasing collaboration in research, rising demand in drug repurposing. Major trends in the forecast period include digital health initiatives, technological advancements in sequencing, ai and machine learning integration, cloud-based solutions, personalized medicine and genomic analysis, integration of blockchain for data security.
The growing adoption of information technology in the healthcare sector is anticipated to significantly enhance the bioinformatics services market in the future. This rise in technology usage has enabled healthcare professionals to elevate the quality of care they deliver to patients, enhance patient safety, improve operational efficiency, reduce costs, and foster better communication among healthcare providers. Bioinformatics services, which leverage computer science and statistics to analyze biological data, rely heavily on IT infrastructure. For example, a report from the National Center for Health Statistics, a U.S. government agency, indicated that in December 2022, 58.5% of adults in the U.S. turned to the Internet for health or medical information, 41.5% used it to connect with doctors or their offices, and 46.1% sought medical test results online. Consequently, the rising integration of information technology in healthcare is propelling the expansion of the bioinformatics services market in the coming years.
The rising demand for personalized medicine is anticipated to significantly drive the expansion of the bioinformatics services market in the future. Personalized medicine is an innovative healthcare approach that considers individual differences in patients' genetics, environments, and lifestyles. Bioinformatics plays a crucial role in personalized medicine by identifying genetic variations, predicting disease risk, analyzing genomic and proteomic data, and safeguarding sensitive health information. For example, the Personalized Medicine Coalition, a non-profit organization based in the U.S., reported that the FDA approved 16 new personalized therapies for patients with rare diseases in 2023, up from six in 2022. Thus, the growing demand for personalized medicine is fueling the growth of the bioinformatics services market moving forward.
Technological advancements serve as a prominent trend shaping the bioinformatics services market, with companies leveraging innovative technologies to fortify their positions. An illustrative example is bitBiome Inc.'s July 2022 launch of the Enzyme Discovery service, leveraging the world's largest microbial genome database (MMGDB) and distinctive bioinformatics technologies. Employing their fundamental technology, bit-MAP, for microbial single-cell genome analysis, bitBiome's service analyzes the human microbiome and environmental bacteria, offering enzyme discovery services through unique bioinformatics and 3D structural modeling technologies.
Leading companies in the bioinformatics services sector prioritize introducing innovative bioinformatic tools offering advanced data solutions, particularly in epigenetic data analysis. FOXO Technologies Inc.'s July 2023 launch of 'Bioinformatics Services' exemplifies this focus, delivering a comprehensive platform equipped with cutting-edge tools for accelerated epigenetic data analysis. These tools significantly boost speed and accuracy in data results, contributing to the processing, analysis, and interpretation of complex disease-related data, thereby expediting research and enhancing comprehension in the field.
In May 2022, ZS, a US-based management consulting company, completed the acquisition of Intomics A/S for an undisclosed amount. This strategic move aims to expand and diversify ZS's portfolio by integrating deep data, scientific expertise, academia, technology, and artificial intelligence. The synergy resulting from this acquisition is expected to expedite drug discovery processes and enhance the probability of success for new pharmaceuticals. Intomics A/S, based in Europe, specializes in bioinformatics and systems biology, operating within the bioinformatics services market.
Major companies operating in the bioinformatics services market include QIAGEN Digital Insights, Thermo Fisher Scientific Inc., Illumina Inc., DNAnexus Inc., PerkinElmer Inc., Biomax Informatics AG, Life Technologies Corporation, BGI Group, Eurofins Scientific SE, NeoGenomics Laboratories Inc., CD Genomics Inc., MedGenome Labs Pvt. Ltd., Fios Genomics Ltd., Geneva Bioinformatics SA, GVK Biosciences Private Limited, Accelrys Inc., Macrogen Inc., GENEWIZ Inc., Source BioScience Limited, Microsynth AG, BaseClear B.V., DNASTAR Inc., GATC Biotech AG, Partek Incorporated, Seven Bridges Genomics Inc., Omixon Inc., BioTeam Inc., BioBam Bioinformatics S.L., Biomatters Limited, Genomatix GmbH, DNASTREAM Limited, Genalice B.V., Golden Helix Inc., Strand Life Sciences Private Limited.
North America was the largest region in the bioinformatics services market in 2024. Europe is expected to be the fastest-growing region in the global bioinformatics services market report during the forecast period. The regions covered in the bioinformatics services market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the bioinformatics services market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Bioinformatics services encompass a broad spectrum of computational tools, resources, and analyses applied in the realm of bioinformatics. These services involve scrutinizing connections between technical and biological variables within studies, encompassing tasks such as sample metadata assessment, data quality control, and standardization across samples.
The primary categories of bioinformatics services include sequencing services, data analysis, drug discovery services, differential gene expression analysis, database management, and various other specialized bioinformatics services. Sequencing services involve deciphering the exact sequence of nucleotides within a given sample. Specialized domains within bioinformatics services span medical biotechnology, animal biotechnology, plant biotechnology, environmental biotechnology, and forensic biotechnology. The applications of these services are diverse, encompassing genomics, chemoinformatics, drug design, proteomics, transcriptomics, metabolomics, and other fields. End-users of bioinformatics services include academic institutes, research centers, hospitals, clinics, pharmaceutical and biotechnology companies, contract research organizations (CROs), and various other end-user entities.
The bioinformatics services market research report is one of a series of new reports that provides bioinformatics services market statistics, including bioinformatics services industry global market size, regional shares, competitors with a bioinformatics services market share, detailed bioinformatics services market segments, market trends and opportunities, and any further data you may need to thrive in the bioinformatics services industry. This bioinformatics services market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The bioinformatics services market includes revenues earned by entities through single-cell analysis, proteomics analysis, metabolomics analysis, and epigenetics analysis. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 3-5 business days.
Table of Contents
1. Executive Summary2. Bioinformatics Services Market Characteristics3. Bioinformatics Services Market Trends and Strategies4. Bioinformatics Services Market - Macro Economic Scenario including the impact of Interest Rates, Inflation, Geopolitics and Covid and Recovery on the Market32. Global Bioinformatics Services Market Competitive Benchmarking and Dashboard33. Key Mergers and Acquisitions in the Bioinformatics Services Market34. Recent Developments in the Bioinformatics Services Market
5. Global Bioinformatics Services Growth Analysis and Strategic Analysis Framework
6. Bioinformatics Services Market Segmentation
7. Bioinformatics Services Market Regional and Country Analysis
8. Asia-Pacific Bioinformatics Services Market
9. China Bioinformatics Services Market
10. India Bioinformatics Services Market
11. Japan Bioinformatics Services Market
12. Australia Bioinformatics Services Market
13. Indonesia Bioinformatics Services Market
14. South Korea Bioinformatics Services Market
15. Western Europe Bioinformatics Services Market
16. UK Bioinformatics Services Market
17. Germany Bioinformatics Services Market
18. France Bioinformatics Services Market
19. Italy Bioinformatics Services Market
20. Spain Bioinformatics Services Market
21. Eastern Europe Bioinformatics Services Market
22. Russia Bioinformatics Services Market
23. North America Bioinformatics Services Market
24. USA Bioinformatics Services Market
25. Canada Bioinformatics Services Market
26. South America Bioinformatics Services Market
27. Brazil Bioinformatics Services Market
28. Middle East Bioinformatics Services Market
29. Africa Bioinformatics Services Market
30. Bioinformatics Services Market Competitive Landscape and Company Profiles
31. Bioinformatics Services Market Other Major and Innovative Companies
35. Bioinformatics Services Market High Potential Countries, Segments and Strategies
36. Appendix
Executive Summary
Bioinformatics Services Global Market Report 2025 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses on bioinformatics services market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
- Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on the latest market shares.
- Benchmark performance against key competitors.
- Suitable for supporting your internal and external presentations with reliable high quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for bioinformatics services? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bioinformatics services market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include:
- The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:
1) By Service: Sequencing Services; Data Analysis; Drug Discovery Services; Differential Gene Expression Analysis; Database and Management Services; Other Services2) By Specialty: Medical Biotechnology; Animal Biotechnology; Plant Biotechnology; Environmental Biotechnology; Forensic Biotechnology
3) By Application: Genomics; Chemoinformatics and Drug Design; Proteomics; Transcriptomics; Metabolomics; Other Applications
4) By End User: Academic Institute and Research Centers; Hospital and Clinics; Pharmaceutical and Biotechnology Companies; CROs; Other End Users
Subsegments:
1) By Sequencing Services: Whole Genome Sequencing; Exome Sequencing; Targeted Sequencing2) By Data Analysis: Genomic Data Analysis; Transcriptomic Data Analysis; Proteomic Data Analysis
3) By Drug Discovery Services: Target Identification; Lead Optimization; Preclinical Development
4) By Differential Gene Expression Analysis: RNA-Seq Analysis; Microarray Analysis
5) By Database and Management Services: Data Storage Solutions; Data Integration Services
6) By Other Services: Consulting Services; Custom Software Development
Key Companies Mentioned: QIAGEN Digital Insights; Thermo Fisher Scientific Inc.; Illumina Inc.; DNAnexus Inc.; PerkinElmer Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Companies Mentioned
- QIAGEN Digital Insights
- Thermo Fisher Scientific Inc.
- Illumina Inc.
- DNAnexus Inc.
- PerkinElmer Inc.
- Biomax Informatics AG
- Life Technologies Corporation
- BGI Group
- Eurofins Scientific SE
- NeoGenomics Laboratories Inc.
- CD Genomics Inc.
- MedGenome Labs Pvt. Ltd.
- Fios Genomics Ltd.
- Geneva Bioinformatics SA
- GVK Biosciences Private Limited
- Accelrys Inc.
- Macrogen Inc.
- GENEWIZ Inc.
- Source BioScience Limited
- Microsynth AG
- BaseClear B.V.
- DNASTAR Inc.
- GATC Biotech AG
- Partek Incorporated
- Seven Bridges Genomics Inc.
- Omixon Inc.
- BioTeam Inc.
- BioBam Bioinformatics S.L.
- Biomatters Limited
- Genomatix GmbH
- DNASTREAM Limited
- Genalice B.V.
- Golden Helix Inc.
- Strand Life Sciences Private Limited
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | February 2025 |
| Forecast Period | 2025 - 2029 |
| Estimated Market Value ( USD | $ 4.78 Billion |
| Forecasted Market Value ( USD | $ 9.38 Billion |
| Compound Annual Growth Rate | 18.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 34 |
